A Pilot Feasibility Study of Activated Charcoal in Healthy Volunteers

Status Completed

Clinical Trial Summary

This is a pilot study designed to test feasibility, tolerability, and safety of medical grade oral Activated Charcoal (AC) in 12 healthy volunteers. To determine the two most palatable and tolerable AC combinations. There will be a total of 4 combinations (2 AC doses and 2 solutions) in stage 1. Each participant will drink an assigned combination every day for 3 consecutive days (Monday, Tuesday, Wednesday, "M/T/W") and switch to a different assigned combination M/T/W the following week. AC solution assignments will be defined before the study using a balanced incomplete block design. Each subject will rate their experience using a 5-point scale every day for the 12 days they are on study.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Healthy Adult Volunteers

Clinical Trial Details

NCT number	NCT04204772
Study type	Interventional
Source	Masonic Cancer Center, University of Minnesota
Contact
Status	Completed
Phase	Early Phase 1
Start date	January 22, 2020
Completion date	March 31, 2021

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT06034899` - A Study to Evaluate the Effect of Food on the Drug Levels of BMS-986196 in Healthy Adult Participants	Phase 1
Completed	`NCT05162274` - Clinical Trial to Assess Bioequivalence of Lazertinib Between Two Formulations in Healthy Volunteers.	Phase 1
Completed	`NCT03748758` - Evaluation of Safety of Repeated Doses of OP0201 Metered Dose Inhaler Compared to Placebo in Healthy Adult Volunteers	Phase 1
Recruiting	`NCT06008652` - A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DR-0201 in Healthy Adult Volunteers	Phase 1
Terminated	`NCT02079480` - Study to Evaluate the Safety, Tolerability, PK, and PD of BMS-986090 in Healthy Subjects	Phase 1
Completed	`NCT01651325` - Drug Interaction Study of Multiple Doses of Isavuconazole and Single Dose of Dextromethorphan in Healthy Adult Subjects	Phase 1
Completed	`NCT01657838` - Drug Interaction Study of the Effect of Ketoconazole at Steady State on the Pharmacokinetics of a Single Dose of Isavuconazole in Healthy Adult Subjects	Phase 1
Completed	`NCT01354379` - Safety and Immunogenicity Study of Inactivated Nasal Influenza Vaccine NB-1008 Administered by Sprayer	Phase 1
Completed	`NCT01129466` - Effects of 2 Different Broccoli Sprout Containing Supplements on Nasal Cells in Healthy Volunteers	N/A
Completed	`NCT04856969` - Clinical Trial to Evaluate Pharmacokinetic Interaction of ATB-1011 and ATB-1012 in Healthy Adult Volunteers	Phase 1
Completed	`NCT01333462` - Safety and Immunogenicity Study of Inactivated Nasal Influenza Vaccine NB-1008	Phase 1
Completed	`NCT02942771` - A MAD Study of TT301/MW189 in Healthy Volunteers	Phase 1
Completed	`NCT02822898` - Metabolism of Isotonic Versus Hypotonic Maintenance Solutions in Fasting Healthy Adults	Phase 4
Completed	`NCT05017987` - Clinical Trial to Compare Pharmacokinetics After Administration of ATB-101 or Co-administration of ATB-1011 and ATB-1012	Phase 1
Not yet recruiting	`NCT05757596` - Study of VSA001 Injection in Chinese Healthy Adult Volunteers	Phase 1
Completed	`NCT05074368` - Efficacy and Safety of Heterologous and Homologous COVID-19 Vaccination	N/A
Completed	`NCT01672242` - Assessment of End Expiratory Lung Volumes in Healthy Subjects Using High Flow Oxygen (Vapotherm®)	N/A
Completed	`NCT03878693` - 4-methylpyrazole and Acetaminophen Metabolism	Early Phase 1
Completed	`NCT05154461` - Intestinal Ketone Bodies Interfere With the Glycemic Control	N/A
Active, not recruiting	`NCT02058472` - Pharmacokinetic/Pharmacodynamic & Safety Study of G3041 and SEVIKAR® Tablet in Healthy Adult Volunteers	Phase 1